Yasuhito Tanaka

Prof. Yasuhito Tanaka

Department of Gastroenterology and Hepatology, Kumamoto University
orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2009 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
YTYasuhito Tanaka
Yasuhito Tanaka
NNNao Nishida
Nao Nishida
MSMasaya Sugiyama
Masaya Sugiyama
MKMasayuki Kurosaki
Masayuki Kurosaki
KMKentaro Matsuura
Kentaro Matsuura
MMMasashi Mizokami
Masashi Mizokami

1 January 2009 in Journal of Hepatology
Verified
Journal Article
Closed access
MYMan-Fung Yuen
Man-Fung Yuen
YTYasuhito Tanaka
Yasuhito Tanaka
Daniel FongDaniel Fong
Daniel Fong
JFJames Fung
James Fung
DWDanny Ka-Ho Wong
Danny Ka-Ho Wong
Ching-Lung LaiChing-Lung Lai
Ching-Lung Lai

1 January 2015 in Immunity
Verified
Journal Article
Closed access
SSSeiichi Sato
Seiichi Sato
KLKai Li
Kai Li
TKTakeshi Kameyama
Takeshi Kameyama
THTakaya Hayashi
Takaya Hayashi
YIYuji Ishida
Yuji Ishida
Akinori TakaokaAkinori Takaoka
Akinori Takaoka

15 October 2009 in Journal of Virology
Verified
Journal Article
Open access
PDF file
KTKanako Tatematsu
Kanako Tatematsu
YTYasuhito Tanaka
Yasuhito Tanaka
FKFuat Kurbanov
Fuat Kurbanov
FSFuminaka Sugauchi
Fuminaka Sugauchi
SMShuhei Mano
Shuhei Mano
MMMasashi Mizokami
Masashi Mizokami
Hepatitis B virus (HBV) of a novel genotype (J) was recovered from an 88-year-old Japanese patient with hepatocellular carcinoma who had a history of residing in Borneo during the World War II. It was divergent from eight human (A to H) and four ape (chimpanzee, gorilla, gibbon, and orangutan) HBV genotypes, as well as from a recently proposed ninth human genotype I, by 9.9 to 16.5% of the entire genomic sequence and did not have evidence of recombination with any of the nine human genotypes and four nonhuman genotypes. Based on a comparison of the entire nucleotide sequence against 1,440 HBV isolates reported, HBV/J was nearest to the gibbon and orangutan genotypes (mean divergences of 10.9 and 10.7%, respectively). Based on a comparison of four open reading frames, HBV/J was closer to gibbon/orangutan genotypes than to human genotypes in the P and large S genes and closest to Australian aboriginal strains (HBV/C4) and orangutan-derived strains in the S gene, whereas it was closer to human than ape genotypes in the C gene. HBV/J shared a deletion of 33 nucleotides at the start of preS1 region with C4 and gibbon genotypes, had an S-gene sequence similar to that of C4, and expressed theaywsubtype. Efficient infection, replication, and antigen expression by HBV/J were experimentally established in two chimeric mice with the liver repopulated for human hepatocytes. The HBV DNA sequence recovered from infected mice was identical to that in the inoculum. Since HBV/J is positioned phylogenetically in between human and ape genotypes, it may help to trace the origin of HBV and merits further epidemiological surveys.

1 August 2010 in Gastroenterology
Verified
Journal Article
Open access
PDF file
MHMasao Honda
Masao Honda
ASAkito Sakai
Akito Sakai
TYTatsuya Yamashita
Tatsuya Yamashita
YNYasunari Nakamoto
Yasunari Nakamoto
EMEishiro Mizukoshi
Eishiro Mizukoshi
HGHokuriku Liver Study Group
Hokuriku Liver Study Group
Multiple viral and host factors are related to the treatment response to pegylated-interferon and ribavirin combination therapy; however, the clinical relevance and relationship of these factors have not yet been fully evaluated. We studied 168 patients with chronic hepatitis C who received pegylated-interferon and ribavirin combination therapy. Gene expression profiles in the livers of 91 patients were analyzed using an Affymetrix genechip (Affymetrix, Santa Clara, CA). The expression of interferon-stimulated genes (ISGs) was evaluated in all samples by real-time polymerase chain reaction. Genetic variation in interleukin 28B (IL28B; rs8099917) was determined in 91 patients. Gene expression profiling of the liver differentiated patients into 2 groups: patients with up-regulated ISGs and patients with down-regulated ISGs. A high proportion of patients with no response to treatment was found in the up-regulated ISGs group (P = .002). Multivariate logistic regression analysis showed that ISGs (<3.5) (odds ratio [OR], 16.2; P < .001), fibrosis stage (F1-F2) (OR, 4.18; P = .003), and ISDR mutation (≥2) (OR, 5.09; P = .003) were strongly associated with the viral response. The IL28B polymorphism of 91 patients showed that 66% were major homozygotes (TT), 30% were heterozygotes (TG), and 4% were minor homozygotes (GG). Interestingly, hepatic ISGs were associated with the IL28B polymorphism (OR, 18.1; P < .001), and its expression was significantly higher in patients with the minor genotype (TG or GG) than in those with the major genotype (TT). The expression of hepatic ISGs is strongly associated with treatment response and genetic variation of IL28B. The differential role of host and viral factors as predicting factors may also be present.

1 July 2006 in The Journal of Bone and Joint Surgery. British volume
Verified
Journal Article
Closed access
Yasuhito TanakaYasuhito Tanaka
Yasuhito Tanaka
YTY. Takakura
Y. Takakura
KHK. Hayashi
K. Hayashi
ATA. Taniguchi
A. Taniguchi
TKT. Kumai
T. Kumai
KSK. Sugimoto
K. Sugimoto
In this retrospective study we have assessed the results of low tibial valgus osteotomy for varus-type osteoarthritis of the ankle and its indications. We performed an opening wedge osteotomy in 25 women (26 ankles). The mean follow-up was for eight years and three months (2 years 3 months to 17 years 11 months). Of the 26 ankles, 19 showed excellent or good clinical results. Their mean scores for pain, walking, and activities of daily living were significantly improved but there was no change in the range of movement. In the ankles which were classified radiologically as stage 2 according to our own grading system, with narrowing of the medial joint space, and in 11 as stage 3a, with obliteration of the joint space at the medial malleolus only, the joint space recovered. In contrast, such recovery was seen in only two of 12 ankles classified as stage 3b, with obliteration of the joint space advancing to the upper surface of the dome of the talus. Low tibial osteotomy is indicated for varus-type osteoarthritis of stage 2 or stage 3a.